Skip to main content
Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.580
-0.010 (-0.63%)
At close: Apr 28, 2026, 4:00 PM EDT
1.590
+0.010 (0.62%)
After-hours: Apr 28, 2026, 7:18 PM EDT

PACB Revenue

In the year 2025, Pacific Biosciences of California had annual revenue of $160.01M with 3.89% growth. Pacific Biosciences of California had revenue of $44.65M in the quarter ending December 31, 2025, with 13.82% growth.

Revenue (ttm)
$160.01M
Revenue Growth
+3.89%
P/S Ratio
2.97
Revenue / Employee
$329,907
Employees
485
Market Cap
477.16M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025160.01M5.99M3.89%
Dec 31, 2024154.01M-46.51M-23.19%
Dec 31, 2023200.52M72.22M56.29%
Dec 31, 2022128.30M-2.21M-1.69%
Dec 31, 2021130.51M51.62M65.43%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Varex Imaging 854.40M
Orthofix Medical 822.31M
Tactile Systems Technology 329.52M
Viemed Healthcare 270.28M
OrthoPediatrics 236.35M
Cerus 206.13M
Cytek Biosciences 201.49M
Beta Bionics 110.24M
Revenue Rankings

PACB News

More News